Renal osteodystrophy in diabetic patients

110Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

To assess the effects of diabetes mellitus on renal osteodystrophy, we examined the database of 256 patients (45% on hemodialysis and 55% on peritoneal dialysis) who were prospectively studied in three Toronto dialysis centers between October of 1987 and 1989. All patients had serial documentation of their clinical, laboratory and risk parameters of bone disease, and completed a series of investigations that included the deferoxamine test, measurement of intact 1-84 PTH levels, and an iliac crest bone biopsy. Twenty-five percent of these patients were diabetic. When compared to non-diabetic patients, they were on dialysis for a shorter duration (2.4 ± 0.3 vs. 4.7 ± 0.3 years; P < 0.0002), used calcium carbonate as the only phosphate binder more frequently (40 vs. 25%; P < 0.007), and had lower parathyroid hormone levels (12 ± 1.4 vs. 24 ± 2.3 pmol/liter; P < 0.002). High-turnover bone disorders (that is, osteitis fibrosa and mixed disorder) were distinctly uncommon (8 vs. 33%; P < 0.01 by Fisher's exact test), while the mild (19 vs. 9%; P = NS) and the aplastic disorders (with mean stainable bone surface aluminum of 6.5 ± 0.7%) (46 vs. 31%; P = NS) tended to be more common in diabetic patients. The prevalence of aluminum bone disease was the same in both groups (27%). Diabetic patients ingested a smaller cumulative dose of aluminum gels (3.7 ± 0.6 vs. 9.3 ± 1.1 kg; P < 0.005), yet had a higher rate of aluminum accumulation on bone surfaces than non-diabetic patients (1.5 ± 0.19 vs. 0.96 ± 0.10% per month on dialysis; P < 0.015). Although the cumulative exposure to aluminum gels remained the major risk factor for aluminum bone disease (P < 0.0001), a positive interaction was noted for diabetic mellitus to increase this risk (P < 0.05). Thus, diabetes mellitus appears to predispose dialysis patients to low bone-turnover states. In addition, it appears to increase aluminum accumulation on bone surfaces and predisposes to aluminum bone disease. The clinical significance of the aplastic disorder remains to be defined.

Cite

CITATION STYLE

APA

Pei, Y., Hercz, G., Greenwood, C., Segre, G., Manuel, A., Saiphoo, C., … Sherrard, D. (1993). Renal osteodystrophy in diabetic patients. Kidney International, 44(1), 159–164. https://doi.org/10.1038/ki.1993.226

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free